BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Genovis’ Board of Directors Has Decided Upon A Private Placement


1/17/2014 9:19:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Following authorization by the Extraordinary General Meeting of November 19, 2013, Genovis’ Board of Directors has decided upon a private placement of a maximum of 804,643 shares in the company. The subscription period runs until January 20 and the subscription price is SEK 4.50, which is the same as in the rights issue with the subscription period December 2 to 16, 2013.The issue will raise a maximum of SEK 3.6 million for the company and share capital could increase by a maximum of SEK 321,857.20. Following the completed private placement, share capital will amount to a maximum of SEK 8,738,260.80 and the number of shares will be a maximum of 21,845,652. The reason for deviation from shareholders’ preferential rights is to be able to take advantage of interest from underwriters within the framework of issued underwriting guarantees in the rights issue with the subscription period December 2-16, 2013.

Help employers find you! Check out all the jobs and post your resume.


Read at GlobeNewswire

Genovis
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES